What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to announce and provide Gilead Sciences, Inc.'s financial results for the quarter ended June 30, 2021, through an accompanying press release.

What types of financial information did Gilead present?

Gilead presented its financial results using both U.S. generally accepted accounting principles (GAAP) and non-GAAP measures. The company believes non-GAAP information is useful for investors, but it should be used to supplement the understanding of GAAP results.

Where can I find the detailed financial results and the reconciliation between GAAP and non-GAAP figures?

The detailed financial results, including the reconciliation between GAAP and non-GAAP financial information, are provided in the press release filed as Exhibit 99.1 to this 8-K report.

Are the financial results in the press release considered 'filed' for legal purposes?

The information in this Form 8-K and its exhibit is furnished and shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into any filings under the Securities Act of 1933 or the Exchange Act.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) announced its financial results for the second quarter ended June 30, 2021, via a press release filed on July 29, 2021. This 8-K filing primarily serves to furnish this press release for investor review. The company provided both GAAP and non-GAAP financial information, with management highlighting the usefulness of non-GAAP measures for internal operating, budgeting, and financial planning purposes. Investors are encouraged to review these non-GAAP figures alongside the company's official GAAP financial statements, recognizing that non-GAAP definitions and calculations may vary across the industry. The press release, which contains detailed financial results and a reconciliation between GAAP and non-GAAP measures, is included as an exhibit to this filing.

Key Highlights

1Gilead Sciences reported its financial results for the second quarter of 2021 on July 29, 2021.
2The company's 8-K filing includes a press release detailing these financial results.
3Both GAAP and non-GAAP financial metrics were presented to investors.
4Management utilizes non-GAAP financial information for internal operational and planning purposes.
5Investors are advised to consider non-GAAP results in conjunction with GAAP financial statements.
6A reconciliation between GAAP and non-GAAP financial figures is available within the press release.
7The press release is furnished as Exhibit 99.1 to the 8-K filing.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Jul 29, 2021)

Summary

Key Highlights

Frequently Asked Questions